Cyclin A2 and Ki-67 proliferation markers could be used to identify tumors with poor prognosis in African American women with breast cancer.
Beyene D, Naab T, Apprey V, Ricks-Santi L, Esnakula A, Qasim M, George M, Minoza KG, Copeland RL, Broome C, Kanaan Y. Cyclin A2 and Ki-67 proliferation markers could be used to identify tumors with poor prognosis in African American women with breast cancer. J Cancer Biol. 2023; 4(1):3-16.